Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia is a research paper published in New England Journal of Medicine (2013). On theSindex it has a DataRank of 18.9. It has been cited 2,265 times, with 200 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
1.2
From this paper's citation signal
Citation Network Contribution
17.8
From 200 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 200 citers.
NCI NIH HHS
Grant: P30 CA016672
NCI NIH HHS
Grant: P01 CA095426
NCI NIH HHS
Grant: K12 CA133250
NCI NIH HHS
Grant: P50 CA140158
NCI NIH HHS
Grant: P01 CA081534
NCI NIH HHS
Grant: P30 CA016058
NCI NIH HHS
Grant: R01 CA177292
FWCI
118.63
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals